Feasibility, Safety and Impact of (18F)-FDG PET/CT in patients with pregnancy-associated cancer: experience of the French CALG (Cancer Associé à La Grossesse) network

Marie Despierresa Department of Gynaecology and Obstetrics, Tenon University Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), Sorbonne University, Paris, France

Anne-Sophie Boudya Department of Gynaecology and Obstetrics, Tenon University Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), Sorbonne University, Paris, France;b Cancer Associé à La Grossesse (CALG), French CALG Network, Paris, FranceCorrespondence[email protected]

https://orcid.org/0000-0002-7308-7632

Lise Sellereta Department of Gynaecology and Obstetrics, Tenon University Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), Sorbonne University, Paris, France;b Cancer Associé à La Grossesse (CALG), French CALG Network, Paris, France

Joseph Gligorovc Department of Oncology, Tenon University Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), Sorbonne University, Paris, France;d UMRS-938 4. Faculté de Médecine Sorbonne Université, Paris, France

Sandrine Richardc Department of Oncology, Tenon University Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), Sorbonne University, Paris, France

Isabelle Thomassind UMRS-938 4. Faculté de Médecine Sorbonne Université, Paris, France;e Department of Radiology, Tenon University Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), Sorbonne University, Paris, France

Yohann Dabia Department of Gynaecology and Obstetrics, Tenon University Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), Sorbonne University, Paris, France;b Cancer Associé à La Grossesse (CALG), French CALG Network, Paris, France

Sonia Zilbermana Department of Gynaecology and Obstetrics, Tenon University Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), Sorbonne University, Paris, France;b Cancer Associé à La Grossesse (CALG), French CALG Network, Paris, France

Cyril Touboula Department of Gynaecology and Obstetrics, Tenon University Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), Sorbonne University, Paris, France;b Cancer Associé à La Grossesse (CALG), French CALG Network, Paris, France;d UMRS-938 4. Faculté de Médecine Sorbonne Université, Paris, France

Françoise Montraversd UMRS-938 4. Faculté de Médecine Sorbonne Université, Paris, France;f Department of Nuclear Medicine, Tenon University Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), Sorbonne University, Paris, France

Kerrou Khaldound UMRS-938 4. Faculté de Médecine Sorbonne Université, Paris, France;f Department of Nuclear Medicine, Tenon University Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), Sorbonne University, Paris, France

Emile Daraia Department of Gynaecology and Obstetrics, Tenon University Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), Sorbonne University, Paris, France;b Cancer Associé à La Grossesse (CALG), French CALG Network, Paris, France;d UMRS-938 4. Faculté de Médecine Sorbonne Université, Paris, France

show all

Feasibility, Safety and Impact of (18F)-FDG PET/CT in patients with pregnancy-associated cancer: experience of the French CALG (Cancer Associé à La Grossesse) network

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Feasibility, Safety and Impact of (18F)-FDG PET/CT in patients with pregnancy-associated cancer: experience of the French CALG (Cancer Associé à La Grossesse) network

Supplemental Material

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date